Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1020959016 | 10209590 | 16 | F | 20140521 | 20160628 | 20140602 | 20160630 | EXP | CA-ROCHE-1409658 | ROCHE | 42.50 | YR | F | Y | 49.00000 | KG | 20160701 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1020959016 | 10209590 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 200 | MG | INFUSION | ||||||||
| 1020959016 | 10209590 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 400 | MG | INFUSION | ||||||||
| 1020959016 | 10209590 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 416 | MG | INFUSION | ||||||||
| 1020959016 | 10209590 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Subcutaneous | 125472 | 162 | MG | QOW | ||||||||
| 1020959016 | 10209590 | 5 | C | TYLENOL WITH CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | 0 | ||||||||||||
| 1020959016 | 10209590 | 6 | C | FISH OIL | FISH OIL | 1 | 0 | ||||||||||||
| 1020959016 | 10209590 | 7 | C | ADALAT | NIFEDIPINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1020959016 | 10209590 | 1 | Rheumatoid arthritis |
| 1020959016 | 10209590 | 4 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1020959016 | 10209590 | OT |
| 1020959016 | 10209590 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1020959016 | 10209590 | Cellulitis | |
| 1020959016 | 10209590 | Eosinophil count decreased | |
| 1020959016 | 10209590 | Injection site erythema | |
| 1020959016 | 10209590 | Injection site pruritus | |
| 1020959016 | 10209590 | Injection site reaction | |
| 1020959016 | 10209590 | Joint swelling | |
| 1020959016 | 10209590 | Ligament sprain | |
| 1020959016 | 10209590 | Neutropenia | |
| 1020959016 | 10209590 | Neutrophil count decreased | |
| 1020959016 | 10209590 | Pain | |
| 1020959016 | 10209590 | Raynaud's phenomenon | |
| 1020959016 | 10209590 | Rheumatoid arthritis | |
| 1020959016 | 10209590 | Rheumatoid factor increased | |
| 1020959016 | 10209590 | Vitamin B12 increased | |
| 1020959016 | 10209590 | Weight decreased | |
| 1020959016 | 10209590 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1020959016 | 10209590 | 1 | 20110919 | 0 | ||
| 1020959016 | 10209590 | 2 | 20120201 | 0 | ||
| 1020959016 | 10209590 | 3 | 20140527 | 20151203 | 0 | |
| 1020959016 | 10209590 | 4 | 20160107 | 0 |